Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 861177 NEW YORK, NY

Position in COGT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,103,853
+$1,733,378 QoQ
Shares Held
209,402
+26.5% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 321 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 37% Shared 0% None 63%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. COGT ranks #45 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in COGT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,103,853 209,402
2026-03-31 $6,370,475 165,510
2025-12-31 $5,830,252 164,140
2025-09-30 $2,052,819 142,954
2025-06-30 $1,487,680 207,198
2025-03-31 $888,197 148,280
2024-12-31 $1,057,710 135,604
2024-09-30 $1,272,919 117,863
2024-06-30 $1,064,008 126,217
2024-03-31 $467,423 69,557
2023-12-31 $350,195 59,557
2023-09-30 $503,655 51,657
2023-06-30 $262,848 22,200
2023-03-31 $239,538 22,200
2022-12-31 $256,632 22,200